Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis
- PMID: 38301596
- DOI: 10.1016/j.jneuroim.2024.578290
Association of peripheral immune activation with amyotrophic lateral sclerosis and Parkinson's disease: A systematic review and meta-analysis
Abstract
Background: Recent studies have revealed the link between immune activation and neurodegenerative diseases.
Methods: By employing meta-analysis, we estimated the standardized mean difference (SMD) and their corresponding 95% confidence intervals (CIs) between the groups.
Results: According to the pre-set criteria, a total of 21 published articles including 2377 ALS patients and 1244 HCs, as well as 60 articles including 5111 PD patients and 4237 HCs, were identified. This study provided evidence of peripheral immune activation in the pathogenesis of ALS and PD.
Conclusion: Our results suggested monitoring changes in peripheral blood immune cell populations, particularly lymphocyte subsets, will benefit understanding the developments and exploring reliable and specific biomarkers of these two diseases.
Keywords: Amyotrophic lateral sclerosis; Meta-analysis; Parkinson's disease; Peripheral blood immune cells.
Copyright © 2024 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Peripheral immune biomarkers and neurodegenerative diseases: A prospective cohort study with 20 years of follow-up.Ann Neurol. 2019 Dec;86(6):913-926. doi: 10.1002/ana.25614. Epub 2019 Oct 18. Ann Neurol. 2019. PMID: 31604369 Free PMC article.
-
CSF and blood biomarkers in amyotrophic lateral sclerosis: protocol for a systematic review and meta-analysis.Syst Rev. 2018 Dec 20;7(1):237. doi: 10.1186/s13643-018-0913-4. Syst Rev. 2018. PMID: 30572951 Free PMC article.
-
Serum anti-Fas antibody levels in amyotrophic lateral sclerosis.J Neuroimmunol. 2003 Sep;142(1-2):137-40. doi: 10.1016/s0165-5728(03)00263-7. J Neuroimmunol. 2003. PMID: 14512172
-
The role of Th17 cells/IL-17A in AD, PD, ALS and the strategic therapy targeting on IL-17A.J Neuroinflammation. 2022 Apr 22;19(1):98. doi: 10.1186/s12974-022-02446-6. J Neuroinflammation. 2022. PMID: 35459141 Free PMC article. Review.
-
T cell-microglial dialogue in Parkinson's disease and amyotrophic lateral sclerosis: are we listening?Trends Immunol. 2010 Jan;31(1):7-17. doi: 10.1016/j.it.2009.09.003. Epub 2009 Oct 31. Trends Immunol. 2010. PMID: 19879804 Free PMC article. Review.
Cited by
-
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders.Cells. 2024 Mar 14;13(6):511. doi: 10.3390/cells13060511. Cells. 2024. PMID: 38534355 Free PMC article. Review.
-
Concomitant Pathologies and Their Impact on Parkinson Disease: A Narrative Overview of Current Evidence.Int J Mol Sci. 2025 Mar 24;26(7):2942. doi: 10.3390/ijms26072942. Int J Mol Sci. 2025. PMID: 40243562 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous